Literature DB >> 25363889

Psoriasis and obesity in French children: a case-control, multicentre study.

E Mahé1, A Beauchet2, C Bodemer3, A Phan4, A-C Bursztejn5, F Boralevi6, A-L Souillet4, C Chiaverini7, E Bourrat8, J Miquel9,10, P Vabres11, S Barbarot12, D Bessis13, C Eschard14, S Hadj-Rabia3.   

Abstract

BACKGROUND: Obesity is more common in adults with psoriasis than in the general population, but there is a lack of data available regarding this association in children.
OBJECTIVES: To evaluate whether obesity was more common in French children with psoriasis of any clinical type or severity.
METHODS: A multicentre case-control study was performed in 23 French dermatology centres. Children without chronic or genetic inflammatory disease were selected as controls and matched for age, sex and dermatology centre. We used three weight cut-off categories to compare the two groups: overweight, overweight with abdominal obesity and overweight with obesity according to the French Health Authority guidelines.
RESULTS: A total of 261 children with psoriasis were included. The mean age was 9.8 years, 126 were boys and 135 were girls. Overall, 42.5% of these children had plaque psoriasis and 32.2% had severe psoriasis. There was no difference between the psoriasis and control groups when the frequency of children who were overweight was compared (20·7% in psoriasis group vs. 17·1% in control group; P = 0·18). Overweight with abdominal obesity including obesity (18·4% vs. 10·4%; P = 0·009) and obesity alone (10·0% vs. 3·1%; P = 0·001) were more common in the psoriasis group.
CONCLUSIONS: This study shows that being overweight with abdominal obesity and being obese is more common in children with psoriasis than in controls. The risk factors are the same as those that affect the French general population, i.e. female sex and having a parent who was overweight. The severity and clinical type of psoriasis do not affect overweight and obesity.
© 2014 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2015        PMID: 25363889     DOI: 10.1111/bjd.13507

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  [Psoriasis vulgaris in children and adolescents. Pathogenesis, clinical picture and therapy].

Authors:  P H Höger; H Hamm
Journal:  Hautarzt       Date:  2015-04       Impact factor: 0.751

2.  Therapeutic Inertia in the Management of Moderate-to-Severe Plaque Psoriasis in Adolescents.

Authors:  Audrey Melin; Jean-François Sei; Florence Corgibet; Cristèle Nicolas; Rémi Maghia; Bruno Halioua; Alain Beauchet; Emmanuel Mahé
Journal:  Acta Derm Venereol       Date:  2021-06-22       Impact factor: 3.875

Review 3.  Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.

Authors:  Stephen Chu-Sung Hu; Cheng-Che E Lan
Journal:  Int J Mol Sci       Date:  2017-10-21       Impact factor: 5.923

4.  Cohort profile: the clinical 'Psoriasis in Adolescents' (PIA) cohort in Denmark.

Authors:  Christoffer Blegvad; Anne-Marie Nybo Andersen; Jonathan Groot; Claus Zachariae; Lone Skov
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

Review 5.  Optimal Management of Plaque Psoriasis in Adolescents: Current Perspectives.

Authors:  Emmanuel Mahé
Journal:  Psoriasis (Auckl)       Date:  2020-11-27

Review 6.  The cardiometabolic conditions of psoriatic disease.

Authors:  Eric Toussirot; Irène Gallais-Sérézal; François Aubin
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

7.  Association of Metabolic Comorbidities with Pediatric Psoriasis: A Systematic Review and Meta-Analysis.

Authors:  Soo Ick Cho; Ye Eun Kim; Seong Jin Jo
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

Review 8.  Interaction of obesity and inflammatory bowel disease.

Authors:  Jason W Harper; Timothy L Zisman
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.